Antibodies to Signaling Molecules and Receptors in Alzheimer's Disease are Associated with Psychomotor Slowing, Depression, and Poor Visuospatial Function.

Giil LM, Vedeler CA, Kristoffersen EK, Nordrehaug JErik, Heidecke H, Dechend R, Schulze-Forster K, Muller DN, von Goetze VS, Cabral-Marques O, et al.
J Alzheimers Dis. 2017; 59(3):929-939. PMID: 28697567. Abstract